XML 27 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Nonvoting Common Stock
Preferred Stock
Common Stock
Common Stock
Common Stock
Common Stock
Nonvoting Common Stock
Additional Paid-In Capital
Retained Earnings
Treasury Stock, at cost
Treasury Stock, at cost
Common Stock
Treasury Stock, at cost
Nonvoting Common Stock
Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period at Dec. 31, 2020 $ 56,060.0     $ 7,733.0   $ 20.0 $ 1.0 $ 26,515.0 $ 21,975.0 $ (5,578.0)     $ 5,394.0
Beginning balance (in shares) at Dec. 31, 2020           1,995 79            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income 5,855.0 [1] $ 5,610.0 $ 245.0           5,855.0        
Other comprehensive income (loss), net of tax (6,503.0)                       (6,503.0)
Issuance of preferred stock, net 2,806.0     2,806.0                  
Redemption of preferred stock (600.0)     (585.0)         (15.0)        
Dividends declared on preferred stock (456.1)               (456.0)        
Dividends declared on common stock (1,367.0)               (1,367.0)        
Stock option exercises and other 221.0             (84.0)   305.0      
Share-based compensation 229.0             229.0          
Other 16.0             81.0   (65.0)      
Balance at end of period at Dec. 31, 2021 56,261.0     9,954.0   $ 20.0 $ 1.0 26,741.0 25,992.0 (5,338.0)     (1,109.0)
Ending balance (in shares) at Dec. 31, 2021           1,995 79            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income 7,183.0 [1] 6,926.0 257.0           7,183.0        
Other comprehensive income (loss), net of tax (21,512.0)                       (21,512.0)
Issuance of preferred stock, net 740.0     740.0                  
Redemption of preferred stock (1,000.0)     (988.0)         (12.0)        
Dividends declared on preferred stock (504.6)               (505.0)        
Dividends declared on common stock (1,592.0)               (1,592.0)        
Repurchase of stock (in shares)         32 15 15            
Repurchase of stock   (2,435.0) (1,000.0)   $ (2,400.0)           $ (2,435.0) $ (1,000.0)  
Conversion of nonvoting common stock to common stock (in shares)           13 (13)            
Stock option exercises and other 64.0             (124.0)   188.0      
Share-based compensation 348.0             348.0          
Other 56.0             110.0   (54.0)      
Balance at end of period at Dec. 31, 2022 36,608.0 [2]     9,706.0   $ 20.0 $ 1.0 27,075.0 31,066.0 (8,639.0)     (22,621.0)
Ending balance (in shares) at Dec. 31, 2022           2,023 51            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income 5,067.0 [1] $ 4,925.0 $ 142.0           5,067.0        
Other comprehensive income (loss), net of tax 4,490.0                       4,490.0
Redemption and repurchase of preferred stock, inclusive of tax (471.0)     (515.0)         44.0        
Dividends declared on preferred stock (438.4)               (438.0)        
Dividends declared on common stock (1,838.0)               (1,838.0)        
Repurchase of stock (in shares)         37                
Repurchase of stock (2,866.0)       $ (2,800.0)         (2,866.0)      
Stock option exercises and other 49.0             (145.0)   194.0      
Share-based compensation 294.0             294.0          
Other 63.0             106.0   (43.0)      
Balance at end of period at Dec. 31, 2023 $ 40,958.0 [2]     $ 9,191.0   $ 20.0 $ 1.0 $ 27,330.0 $ 33,901.0 $ (11,354.0)     $ (18,131.0)
Ending balance (in shares) at Dec. 31, 2023           2,023 51            
[1] Certain prior year amounts have been reclassified to conform to the current year presentation. See Note 1 for additional information.
[2] Certain prior year amounts have been reclassified to conform to the current year presentation. See Note 1 for additional information.